Administrators seek to recover $71 million from FTX’s philanthropic and life science arms
Administrators for FTX are attempting to recover over $71 million from the bankrupt exchange’s philanthropic and life science entities. The FTX Foundation and Latona life sciences fund, led by Sam Bankman-Fried, received this investment from FTX and Alameda Research. The funds were allocated to various life sciences companies between February and October 2022.
Key Points:
- Investment made in life sciences field from February to October 2022
- Companies receiving funds include Lumen Bioscience, GreenLight Biosciences, Genetic Networks, and 4J Therapeutics
- Lawyers argue the donations were made for Bankman-Fried’s personal gain
- FTX Foundation and Latona accused of taking funds for Bankman-Fried’s personal aggrandizement
- Efforts to recover funds for creditors ongoing
The court documents filed by FTX administrators claim that the FTX Foundation and Latona, organized as a non-profit in the Bahamas, used commingled funds from Alameda and FTX accounts to make investments and donations in the life sciences sector. However, it is alleged that these transactions were made to boost Bankman-Fried’s reputation and influence rather than for altruistic purposes.
This recent move by the bankrupt firm follows previous efforts to recover funds. Last month, Alameda Research’s lawyers sought the recovery of $700 million allegedly transferred by Bankman-Fried to a former aide of Hillary Clinton and investment firm K5 Global in 2022. The lawsuit names several entities, including K5 Global and its co-owners, as defendants.
Hot Take:
The attempt to recover funds from FTX’s philanthropic and life science arms highlights the alleged misuse of funds by Sam Bankman-Fried and his associated entities. These legal actions reflect the ongoing battle to hold individuals accountable for their actions within the crypto space. It serves as a reminder for investors to exercise caution and due diligence when engaging in cryptocurrency transactions.